All filters
Slidesets
Patients in Germany - Heiner Wedemeyer, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Holland - Rob de Knegt, MD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Patients in Spain - Maria Buti, MD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
Resistance Case and Preventing Resistance - Stéphane Chevaliez, PharmD, PhD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
German Hepatitis C Resistance Registry - Christophe Sarrazin, MD
Presented at:
Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015
Slidesets
The Toronto Declaration - Where are we now? - Jordan Feld, MD, MPH
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Hepatitis C Vaccines: Are we making progress? - Christopher M. Walker, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
A hepatitis C Vaccine: How do we prove it works? - Kimberly Page
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Point-of-care (POC) testing in Hepatitis B and C - Scott Bowden, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Hepatitis B Vaccine: Optimizing coverage and efficacy - Alex Vorsters, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Baby Boomer Screening in the U.S: Delivering on the promise thus far? - John Ward, MD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
New Treatment Strategies for Hepatitis B - Harry Janssen, MD, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
New tools for testing and monitoring Hepatitis B and C - Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Maximizing SVR with current HCV therapy - Alnoor Ramji, MD, FRCP
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
New Treatment in HCV: Is there need for more therapies? - Jordan Feld, MD, MPH
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Hepatitis C treatment in resource-limited countries - Gamal Esmat, MD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Perspective from health economics - David Rein, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Perspective from Civil Society - Tracy Swan
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Perspective from Payers - Mel Krajden, MD, FRCPC & Bonnie Henry, MD, MPH, FRCPC
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Perspective from Medical Community - Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Rational pricing and the role of generics - Raymond Schinazi, PhD, DSc
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Basic Science of Integrase Inhibitors - François Clavel, MD
Presented at:
HIV Clinical Forum 2015
Slidesets
Pharmacological considerations - Marta Boffito, MD, PhD, FRCP
Presented at:
HIV Clinical Forum 2015